Carvedilol (Carelol (6.25 mg)) is an alpha- and beta-blocker, prescribed for heart failure and high blood pressure. It relaxes blood vessels and slowing heart rate to improve blood flow and decreases ...

Please provide your email address to receive an email when new articles are posted on . A low-dose regimen of the blood pressure medication carvedilol demonstrated safety and efficacy in improving ...

Endoscopic band ligation (EBL) and nonselective β-blockade are two effective strategies in the primary prevention of variceal bleeding. Meta-analyses have shown an advantage of EBL over propranolol ...

Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...

The goal of the trial was to evaluate treatment with carvedilol compared with placebo among children with heart failure. Patients were randomized in a double-blind manner to placebo (n = 55), low-dose ...

London, UK - The Carvedilol or Metoprolol European Trial (COMET) trial, showing improved survival with carvedilol over metoprolol, has now been published in the July 5, 2003 issue of the Lancet. The ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...